Literature DB >> 10811840

Meeting Koch's postulates for calcium signaling in cardiac hypertrophy.

K R Chien1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10811840      PMCID： PMC315474          DOI： 10.1172/JCI10079

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  60 in total

1.  Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure.

Authors:  M I Miyamoto; F del Monte; U Schmidt; T S DiSalvo; Z B Kang; T Matsui; J L Guerrero; J K Gwathmey; A Rosenzweig; R J Hajjar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

2.  Revisiting calcineurin and human heart failure.

Authors:  L Tsao; C Neville; A Musaro; K J McCullagh; N Rosenthal
Journal:  Nat Med       Date:  2000-01       Impact factor: 53.440

3.  Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy.

Authors:  T Taigen; L J De Windt; H W Lim; J D Molkentin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

4.  Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling.

Authors:  P Paradis; N Dali-Youcef; F W Paradis; G Thibault; M Nemer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

5.  Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy.

Authors:  M Shimoyama; D Hayashi; E Takimoto; Y Zou; T Oka; H Uozumi; S Kudoh; F Shibasaki; Y Yazaki; R Nagai; I Komuro
Journal:  Circulation       Date:  1999-12-14       Impact factor: 29.690

Review 6.  Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins.

Authors:  B L Black; E N Olson
Journal:  Annu Rev Cell Dev Biol       Date:  1998       Impact factor: 13.827

7.  Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy.

Authors:  S Minamisawa; M Hoshijima; G Chu; C A Ward; K Frank; Y Gu; M E Martone; Y Wang; J Ross; E G Kranias; W R Giles; K R Chien
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

8.  RXRalpha overexpression in cardiomyocytes causes dilated cardiomyopathy but fails to rescue myocardial hypoplasia in RXRalpha-null fetuses.

Authors:  V Subbarayan; M Mark; N Messadeq; P Rustin; P Chambon; P Kastner
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

9.  CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.

Authors:  R Passier; H Zeng; N Frey; F J Naya; R L Nicol; T A McKinsey; P Overbeek; J A Richardson; S R Grant; E N Olson
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

10.  A transgenic rabbit model for human hypertrophic cardiomyopathy.

Authors:  A J Marian; Y Wu; D S Lim; M McCluggage; K Youker; Q T Yu; R Brugada; F DeMayo; M Quinones; R Roberts
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808
View more
  14 in total

1.  Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes.

Authors:  N H Purcell; G Tang; C Yu; F Mercurio; J A DiDonato; A Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

2.  Cardiac expression of Gal4 causes cardiomyopathy in a dose-dependent manner.

Authors:  Petra E M H Habets; Danielle E W Clout; Ronald H Lekanne Deprez; Marian A van Roon; Antoon F M Moorman; Vincent M Christoffels
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

3.  Flow in the early embryonic human heart: a numerical study.

Authors:  C G DeGroff; B L Thornburg; J O Pentecost; K L Thornburg; M Gharib; D J Sahn; A Baptista
Journal:  Pediatr Cardiol       Date:  2003-03-14       Impact factor: 1.655

Review 4.  CaMKII, an emerging molecular driver for calcium homeostasis, arrhythmias, and cardiac dysfunction.

Authors:  Chad E Grueter; Roger J Colbran; Mark E Anderson
Journal:  J Mol Med (Berl)       Date:  2006-11-21       Impact factor: 4.599

Review 5.  The Ca2+ ATPase of cardiac sarcoplasmic reticulum: Physiological role and relevance to diseases.

Authors:  Giuseppe Inesi; Anand Mohan Prasad; Rajendra Pilankatta
Journal:  Biochem Biophys Res Commun       Date:  2007-12-07       Impact factor: 3.575

6.  BET bromodomain proteins regulate transcriptional reprogramming in genetic dilated cardiomyopathy.

Authors:  Andrew Antolic; Hiroko Wakimoto; Zhe Jiao; Joshua M Gorham; Steven R DePalma; Madeleine E Lemieux; David A Conner; Da Young Lee; Jun Qi; Jonathan G Seidman; James E Bradner; Jonathan D Brown; Saptarsi M Haldar; Christine E Seidman; Michael A Burke
Journal:  JCI Insight       Date:  2020-08-06

7.  An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy.

Authors:  D Fatkin; B K McConnell; J O Mudd; C Semsarian; I G Moskowitz; F J Schoen; M Giewat; C E Seidman; J G Seidman
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

8.  Transient receptor potential channels contribute to pathological structural and functional remodeling after myocardial infarction.

Authors:  Catherine A Makarewich; Hongyu Zhang; Jennifer Davis; Robert N Correll; Danielle M Trappanese; Nicholas E Hoffman; Constantine D Troupes; Remus M Berretta; Hajime Kubo; Muniswamy Madesh; Xiongwen Chen; Erhe Gao; Jeffery D Molkentin; Steven R Houser
Journal:  Circ Res       Date:  2014-07-21       Impact factor: 17.367

9.  Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo.

Authors:  Christopher L Antos; Timothy A McKinsey; Norbert Frey; William Kutschke; John McAnally; John M Shelton; James A Richardson; Joseph A Hill; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

10.  Changes of expression of stretch-activated potassium channel TREK-1 mRNA and protein in hypertrophic myocardium.

Authors:  Longxian Cheng; Fengcheng Su; Nsenga Ripen; Hong Fan; Kai Huang; Min Wang; Hongyu Peng; Chunli Mei; Fang Zhao; Yuhua Liao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.